993.64
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Eli Lilly to invest $6B in Limestone manufacturing facility - timesdaily.com
Did Eli Lilly's (LLY) US$6 Billion Alabama Bet on Orforglipron Just Shift Its Investment Narrative? - Yahoo Finance
Locals weigh in on new Eli Lilly plant coming to Huntsville - rocketcitynow.com
How Investors May Respond To Eli Lilly (LLY) Doubling Down On Manufacturing And Oncology Beyond Obesity - simplywall.st
UAH, Calhoun weigh in on Eli Lilly plant coming to North Alabama - WHNT.com
Limestone Co. officials weigh in on infrastructure concerns regarding Eli Lilly coming to Huntsville - WAFF
Lilly To Build $6B Pharmaceutical Manufacturing Facility In Alabama - InkFreeNews.com
Eli Lilly (LLY) Rebounds Amid Takeover Speculation and Strategic Expansion - GuruFocus
Warning: This Skyrocketing Stock Has a Hidden Risk - AOL.com
Eli Lilly ends in green after nine consecutive sessions of decline - Seeking Alpha
Major pharmaceutical company to build $6B facility creating over 3,000 jobs - MassLive
Lilly - timesdaily.com
Warning: This Skyrocketing Stock Has a Hidden Risk - The Motley Fool
Eli Lilly's Weight-Loss Drugs Drove Its Stock Higher This Year. A New Plant in Alabama Could Boost Production - Investopedia
Wells Fargo Raises Price Target for Eli Lilly (LLY) to $1200 wit - GuruFocus
Lilly to Build Third, $6B Manufacturing Plant - Powder & Bulk Solids
Eli Lilly CEO David Ricks Unveils $6B Alabama Plant to Produce New Obesity Pill - International Business Times UK
Eli Lilly to build GLP-focused $6bn manufacturing facility in Alabama - BioProcess International
Eli Lilly Announces $6 Billion Manufacturing Facility in Huntsville - Meyka
Eli Lilly to spend $6B on AL plant for next-gen drugs. What to know - Montgomery Advertiser
Eli Lilly and Company (LLY) Announces Results From Phase 3 BRUIN CLL-314 Trial Evaluating Jaypirca Versus Imbruvica - Insider Monkey
Rail NewsNorfolk Southern to serve new Eli Lilly plant in Alabama. For Railroad Career Professionals - Progressive Railroading
Eli Lilly building new $6B manufacturing facility in Alabama - The Bama Buzz
Abivax stock pops on Eli Lilly takeover speculation - Proactive Investors
Eli Lilly Plans $6B Investment in New Alabama Manufacturing Site - Yahoo Finance UK
Eli Lilly (LLY) Stock: Company Drops $6 Billion on Alabama Plant for Weight Loss Pill - parameter.io
Eli Lilly to build new $6 billion facility in Huntsville - Hville Blast
Eli Lilly (LLY) to Build New $6 Billion Manufacturing Plant in Alabama - TipRanks
French biotech Abivax's shares climb on Eli Lilly bid rumors - MSN
Skip The Market Darling Eli Lilly; Buy The Underdog Novo Nordisk (NYSE:NVO) - Seeking Alpha
Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push - Reuters
Drug giant Eli Lilly announces major manufacturing facility in Huntsville - Alabama Daily News
Eli Lilly announces $6 billion manufacturing plant in Huntsville - Alabama Political Reporter
Lilly’s $6B decision marks an ecosystem transformation for North Alabama - 256 Today
Eli Lilly's $6 Billion Alabama Site To Make Next-Gen Weight Loss Pills - Benzinga
Eli Lilly declines to comment on market talk about Abivax interest - marketscreener.com
Lilly to establish third new US manufacturing facility in Alabama - European Pharmaceutical Review
Eli Lilly acquisition rumors reportedly fuel Abivax rally - MSN
Eli Lilly acquisition rumors fuel Abivax rally (ABVX:NASDAQ) - Seeking Alpha
Eli Lilly makes Alabama history with $6B Huntsville plant - Axios
Wells Fargo Adjusts PT on Eli Lilly and Company to $1,200 From $1,100, Maintains Overweight Rating - marketscreener.com
HSBC Adjusts PT on Eli Lilly and Company to $1,070 From $850, Maintains Hold Rating - marketscreener.com
Eli Lilly to Invest $6 Billion in New Alabama Manufacturing Plant - Yahoo Finance
Drug firm Eli Lilly to build $6bn Alabama manufacturing plant - Construction Briefing
Abivax pops 19% on rumor of Eli Lilly takeover interest - breakingthenews.net
Abivax Soars on Rumored Interest from Eli Lilly - marketscreener.com
Eli Lilly picks Alabama as home to $6bn orforglipron manufacturing facility - Pharmaceutical Technology
Eli Lilly (LLY) Stock: Drugmaker Announces $6 Billion Alabama Plant for Obesity Pill Production - CoinCentral
Inside Eli Lilly’s $6 Billion Bet to Rebuild Drug Manufacturing in USA - AIM Media House
Eli Lilly to Build $6 Billion Drug Production Plant in Alabama - marketscreener.com
Eli Lilly to invest $6 billion in new Limestone manufacturing facility - Decatur Daily
Pharm giant Eli Lilly to spend 6 billion on Alabama plant - mynbc15.com
City leaders say Eli Lilly location was hand-picked years ago - WAFF
Alabama's Largest Investment In History Brings 450 Permanent Jobs To Greenbrier - Tuscaloosa Thread
Eli Lilly to build $6 billion manufacturing plant in Huntsville - WVTM
Eli Lilly CEO To CNN: Data shows Ozempic-like drugs "extend life" - CNN
Economic experts weigh in on Eli Lilly coming to the Rocket City - WAFF
Eli Lilly to invest $6 billion in Huntsville, creating 450 jobs - WBMA
With $6B Eli Lilly facility coming, Huntsville is launching its way to biopharma prominence - 256 Today
Eli Lilly announces $6B plant for Huntsville, adding 3,450 jobs - rocketcitynow.com
Pharmaceutical giant Eli Lilly announces plans for $6B manufacturing plant in Huntsville - Fox 59
Eli Lilly announces $6 billion pharmaceutical manufacturing investment in Huntsville - City of Huntsville (.gov)
Governor Ivey Announces Pharmaceutical Giant Lilly Plans $6 Billion Advanced Manufacturing Plant in Huntsville - Alabama Governor's Office (.gov)
'Ideal location': Eli Lilly and Company announces plans for $6 billion manufacturing facility in Huntsville - 1819 News
Eli Lilly to build $6B API manufacturing plant in Alabama - Seeking Alpha
In Alabama, Eli Lilly To Invest $6B In GLP-1 Manufacturing Site - Business Facilities
Eli Lilly Announces New $6 Billion Plant | Dec. 9, 2025 | News 19 at 4 p.m. - WKRG
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):